Use of Exogenous Hormones and Risks of Breast and Ovarian Cancers in BRCA1/2 Mutation Carriers; Methodological and Clinical Considerations
Crossref DOI link: https://doi.org/10.1007/s12609-014-0145-0
Published Online: 2014-05-02
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schrijver, Lieske H.
Jansen, Susanne
van der Baan, Frederieke H.
Rookus, Matti A.
Text and Data Mining valid from 2014-05-02